Cardioprotective effect of mangiferin on left ventricular remodeling in rats

Pharmacology

Volumn 90, Issue 1-2, 2012, Pages 78-87

  Zheng, Dezhi ^a   Hou, Jun ^b   Xiao, Yingbin ^a   Zhao, Zhe ^c   Chen, Lin ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b CHENGDU MILITARY GENERAL HOSPITAL   (China)

^c NAVY GENERAL HOSPITAL   (China)

Author keywords

Left ventricular remodeling; Mangiferin; Myocardial infarction; p38 mitogen activated protein kinase

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; MANGIFERIN; MITOGEN ACTIVATED PROTEIN KINASE P38; RAMIPRIL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL MODEL; HEART FUNCTION TEST; HEART INFARCTION; HEART LEFT VENTRICLE REMODELING; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART PROTECTION; HEART VENTRICLE REMODELING; HISTOPATHOLOGY; MALE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SIGNAL TRANSDUCTION; TRANSTHORACIC ECHOCARDIOGRAPHY; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOOD PRESSURE; CARDIOTONIC AGENTS; CASPASE 3; DRUGS, CHINESE HERBAL; FIBROSIS; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR REMODELING; XANTHONES;

EID: 84863084830     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000339450     Document Type: Article

References (22)

1. Solomon SD, Shin SH, Shah A, et al: Effect of the direct renin inhibitor aliskiren on left ventricular remodeling following myocardi-al infarction with systolic dysfunction. Eur Heart J 2011;32:1227-1234.
2. Zhu M, Feng J, Lucchinetti E, et al: Ischemic postconditioning protects remodeled myocardium via the PI3K-PKB/Akt reperfusion injury salvage kinase pathway. Cardiovasc Res 2006;72:152-162.
3. Opie LH, Commerford PJ, Gersh BJ, Pfeffer MA: Controversies in ventricular remodeling. Lancet 2006;367:356-367.
4. Yin HQ, Wang B, Zhang JD, et al: Effect of traditional Chinese medicine Shu-Mai-Tang on attenuating TNF alpha-induced myocar-dial fibrosis in myocardial ischemia rats. J Ethnopharmacol 2008;118:133-139.
5. Kim YS, Park HJ, Hong MH, et al: TNF-al-pha enhances engraftment of mesenchymal stem cells into infarcted myocardium. Front Biosci 2009;14:2845-2856.
6. Matsumoto-Ida M, Takimoto Y, Aoyama T, Akao M, Takeda T, Kita T: Activation of TGF-beta1-TAK1-p38 MAPK pathway in spared cardiomyocytes is involved in left ventricular remodeling after myocardial infarction in rats. Am J Physiol Heart Circ Physiol 2006;290:H709-H715.
7. 2+-citrate. Eur J Pharmacol 2005;513:47-55.
8. Muruganandan S, Gupta S, Kataria M, Lal J, Gupta PK: Mangiferin protects the strepto-zotocin-induced oxidative damage to cardiac and renal tissues in rats. Toxicology 2002; 176:165-173.
9. Leiro JM, Alvarez E, Arranz JA, Siso IG, Oral-lo F: In vitro effects of mangiferin on super-oxide concentrations and expression of the inducible nitric oxide synthase, tumour necrosis factor-alpha and transforming growth factor-beta genes. Biochem Pharmacol 2003;65:1361-71.
10. Prabhu S, Jainu M, Sabitha KE, Devi CS: Role of mangiferin on biochemical alterations and antioxidant status in isoprotere-nol-induced myocardial infarction in rats. J Ethnopharmacol 2006;107:126-133.
11. Prabhu S, Jainu M, Sabitha KE, Shyamala Devi CS: Effect of mangiferin on mitochon-drial energy production in experimentally induced myocardial infarcted rats. Vasc Pharmacol 2006;44:519-525.
12. Frantz S, Tillmanns J, Kuhlencordt PJ, et al: Tissue-specific effects of the nuclear factor kappaB subunit p50 on myocardial ischemia-reperfusion injury. Am J Pathol 2007;171: 507-512.
13. Zhu J, Qiu Y, Wang Q, et al: Low dose cy-clophosphamide rescues myocardial function from ischemia-reperfusion in rats. Eur J Cardiothorac Surg 2008;34:661-666.
14. Zhang S, Li H, Yang SJ: Tribulosin protects rat hearts from ischemia/reperfusion injury. Acta Pharmacol Sin 2010;31:671-678.
15. Rong F, Peng Z, Ye MX, et al: Myocardial apoptosis and infarction after ischemia/re-perfusion are attenuated by kappa-opioid receptor agonist. Arch Med Res 2009;40: 227-234.
16. Li C, Gao Y, Tian J, Shen J, Xing Y, Liu Z: Sophocarpine administration preserves myocardial function from ischemia-reper-fusion in rats via NF-kappaB inactivation. J Ethnopharmacol 2011;135:620-625.
17. Martinez PF, Okoshi K, Zornoff LA, et al: Echocardiographic detection of congestive heart failure in postinfarction rats. J Appl Physiol 2011;111:543-551.
18. Zhou L, Azfer A, Niu J, et al: Monocyte che-moattractant protein-1 induces a novel transcription factor that causes cardiac myocyte apoptosis and ventricular dysfunction. Circ Res 2006;98:1177-1185.
19. Wang YL, Wang CY, Zhang BJ, Zhang ZZ: Shenfu injection suppresses apoptosis by regulation of Bcl-2 and caspase-3 during hypoxia/reoxygenation in neonatal rat car-diomyocytes in vitro. Mol Biol Rep 2009;36: 365-370.
20. Abdel-Latif AM, Abuel-Ela HA, El-Shour-bagy SH: Increased caspase-3 and altered expression of apoptosis-associated proteins, Bcl-2 and Bax in lichen planus. Clin Exp Dermatol 2009;34:390-395.
21. Liao P, Georgakopoulos D, Kovacs A, et al: The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardio-myopathy. Proc Natl Acad Sci USA 2001;98: 12283-12288.
22. Li M, Georgakopoulos D, Lu G, et al: p38 MAP kinase mediates inflammatory cytokine induction in cardiomyocytes and extracellular matrix remodeling in heart. Circulation 2005;111:2494-2502.